Ascendia Pharmaceuticals is a company that specializes in the invention and development of specialty pharmaceutical products and formulation technologies. It delivers formulations of existing drug products as well as preclinical- and clinical-stage drug candidates utilizing nanoparticle technologies. Additionally, the company offers special development programs, such as formulations for poorly soluble and low bioavailability drugs, first-in-man injectable formulations, nano-emulsion and nano-particle formulations, peptide formulations, etc.